PRESS RELEASE published on 08/05/2026 at 22:15, 2 months 30 days ago Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity Zomedica reports record $9 million revenue in Q2 2026, marking 22 consecutive quarters of growth. Expansion in international markets and strong product portfolio drive success Revenue Growth Zomedica Animal Health Record Q2 2026
BRIEF published on 08/04/2026 at 12:05, 3 months ago Zomedica lance un silencieux acoustique pour PulseVet Zomedica Innovation Vétérinaire Silencieux Acoustique PulseVet Réduction Du Bruit Efficacité Thérapeutique
BRIEF published on 08/04/2026 at 12:05, 3 months ago Zomedica Introduces Noise-Reducing Acoustic Muffler for PulseVet Zomedica Noise Reduction Veterinary Innovation PulseVet Acoustic Muffler Therapeutic Efficacy
PRESS RELEASE published on 08/04/2026 at 12:00, 3 months ago Zomedica Launches the PulseVet Acoustic Muffler(TM) Accessory for PulseVet(R) Shock Wave System Zomedica launches PulseVet Acoustic Muffler accessory to reduce sound during shock wave therapy for animals, maintaining clinical efficacy. Designed to improve treatment experience Zomedica Pulsevet Shock Wave Therapy Veterinary Acoustic Muffler
BRIEF published on 07/15/2026 at 12:05, 3 months 20 days ago Zomedica organise un webinaire sur sa stratégie de vente Stratégie De Vente Croissance Commerciale Webinaire Zomedica Pratiques Vétérinaires Intégration De Produits
BRIEF published on 07/15/2026 at 12:05, 3 months 20 days ago Zomedica to Host Webinar Highlighting Sales Strategy Commercial Growth Sales Strategy Veterinary Practices Zomedica Webinar Product Integration
PRESS RELEASE published on 07/15/2026 at 12:00, 3 months 20 days ago Zomedica Announces "Fourth Friday at Four" Webinar on July 24, 2026: Zomedica's Sales Organization - From Strategy to the Clinic Zomedica Corp. announces webinar on its specialized sales organization's role in product adoption and revenue growth. Investors to gain insight into the Company's structure and strategies Webinar Zomedica Corp. Sales Organization Veterinary Practices Product Adoption
BRIEF published on 06/25/2026 at 12:05, 4 months 9 days ago Zomedica Partners with Fear Free to Promote Low-Stress Pet Care Non-invasive Treatments Pet Care Partnership Zomedica And Fear Free Low-Stress Animal Therapy Veterinary Stress Reduction
BRIEF published on 06/25/2026 at 12:05, 4 months 9 days ago Zomedica s'associe à Fear Free pour promouvoir des soins pour animaux de compagnie sans stress Traitements Non Invasifs Partenariat Pour Les Soins Aux Animaux De Compagnie Zomedica Et Fear Free Thérapie Animale À Faible Stress Réduction Du Stress Chez Les Vétérinaires
PRESS RELEASE published on 06/25/2026 at 12:00, 4 months 9 days ago Zomedica's Assisi Loop(R) Products Designated "Fear Free(R)" as Alliance to Advance Low Stress Care and Pet Wellbeing Continues with Fear Free, LLC Zomedica and Fear Free renew partnership to enhance companion animal wellbeing with Assisi Loop tPEMF™ therapy, reducing stress and improving clinical outcomes Companion Animals Zomedica Fear Free Assisi Loop TPEMF Therapy Low-stress Handling
Published on 11/04/2026 at 23:10, 3 hours 32 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 3 hours 42 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 4 hours 27 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 4 hours 37 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 00:02, 2 hours 39 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 7 hours ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 7 hours 16 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 7 hours 58 minutes ago EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:05, 8 hours 36 minutes ago Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
Published on 11/04/2026 at 18:00, 8 hours 41 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 8 hours 41 minutes ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 8 hours 58 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026